172 related articles for article (PubMed ID: 15213721)
1. Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value.
Herrlinger U; Wiendl H; Renninger M; Förschler H; Dichgans J; Weller M
Br J Cancer; 2004 Jul; 91(2):219-24. PubMed ID: 15213721
[TBL] [Abstract][Full Text] [Related]
2. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
[TBL] [Abstract][Full Text] [Related]
3. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Reijneveld JC; Brandsma D; Boogerd W; Bonfrer JG; Kalmijn S; Voest EE; Geurts-Moespot A; Visser MC; Taphoorn MJ
Neurology; 2005 Oct; 65(7):1120-2. PubMed ID: 16217072
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
6. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal metastasis: survival and prognostic factors in 155 patients.
Herrlinger U; Förschler H; Küker W; Meyermann R; Bamberg M; Dichgans J; Weller M
J Neurol Sci; 2004 Aug; 223(2):167-78. PubMed ID: 15337619
[TBL] [Abstract][Full Text] [Related]
8. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
[TBL] [Abstract][Full Text] [Related]
9. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H
Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732
[TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study.
Bok RA; Halabi S; Fei DT; Rodriquez CR; Hayes DF; Vogelzang NJ; Kantoff P; Shuman MA; Small EJ
Cancer Res; 2001 Mar; 61(6):2533-6. PubMed ID: 11289126
[TBL] [Abstract][Full Text] [Related]
12. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study.
Poon RT; Lau C; Yu WC; Fan ST; Wong J
Oncol Rep; 2004 May; 11(5):1077-84. PubMed ID: 15069550
[TBL] [Abstract][Full Text] [Related]
13. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
14. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
Tamura M; Ohta Y
Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
[TBL] [Abstract][Full Text] [Related]
15. Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.
Wu Y; Saldana L; Chillar R; Vadgama JV
Int J Oncol; 2002 Mar; 20(3):509-16. PubMed ID: 11836562
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.
Werther K; Christensen IJ; Nielsen HJ;
Br J Cancer; 2002 Feb; 86(3):417-23. PubMed ID: 11875709
[TBL] [Abstract][Full Text] [Related]
17. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
Linderholm B; Tavelin B; Grankvist K; Henriksson R
Br J Cancer; 1999 Oct; 81(4):727-32. PubMed ID: 10574263
[TBL] [Abstract][Full Text] [Related]
18. The expression of ER beta protein correlates with vascular endothelial growth factor and its prognostic significance in human breast cancer.
Wen XF; Shen Z; Shen ZZ; Nguyen M; Shao ZM
Oncol Rep; 2002; 9(5):937-44. PubMed ID: 12168051
[TBL] [Abstract][Full Text] [Related]
19. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
